Filter
1342
Filtered Results: 1342
Text search:
World
Health
Organization,
Western
Pacific
Featured
Recommendations
150
New Publications
316
Language
Document type
No document type
612
Studies & Reports
335
Guidelines
205
Manuals
74
Strategic & Response Plan
50
Training Material
18
Fact sheets
15
Situation Updates
13
Resource Platforms
11
Infographics
8
Online Courses
1
Countries / Regions
Global
123
Philippines
44
South–East Asia Region
28
Western Pacific Region
28
India
23
Asia
21
Nepal
20
Africa
20
Western and Central Europe
20
Cambodia
19
Myanmar / Burma
19
Kenya
14
Bangladesh
14
Latin America and the Carribbean
13
Liberia
10
Nigeria
9
Congo, Democratic Republic of
9
Russia
9
Sierra Leone
8
China
8
Ethiopia
8
Indonesia
8
Rwanda
7
Syria
7
Afghanistan
7
Middle East and North Africa
7
South Africa
7
Thailand
6
Ukraine
6
Eastern Europe and Central Asia
6
Eastern Europe
6
Papua New Guinea
6
Tanzania
5
South Sudan
5
Pakistan
5
Ghana
4
Malawi
4
Mozambique
4
West and Central Africa
4
East and Southern Africa
4
Yemen
4
Somalia
4
Madagascar
4
Zimbabwe
3
Guinea
3
Venezuela
3
Vietnam
3
Sri Lanka
3
Iran
2
Fiji
2
Laos
2
Senegal
2
Peru
2
Mongolia
2
USA
2
Haiti
2
Uganda
2
Zambia
2
Ecuador
2
North Korea
1
Colombia
1
Timor Leste/ East Timor
1
Mexico
1
Serbia
1
Benin
1
Cameroon
1
Niger
1
Burkina Faso
1
Vanuatu
1
Jordan
1
Japan
1
Brazil
1
Moldova
1
Namibia
1
Egypt
1
Sudan
1
Palestine
1
Central African Republic
1
Bhutan
1
Botswana
1
Iraq
1
Solomon Islands
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
241
Clinical Guidelines
166
Public Health
98
Women & Child Health
90
Key Resources
85
Capacity Building
25
Pharmacy & Technologies
25
Toolboxes
HIV
143
Mental Health
128
COVID-19
95
Planetary Health
88
Rapid Response
71
TB
61
NTDs
59
Global Health Education
52
AMR
43
Disability
42
Caregiver
40
Pharmacy
34
Malaria
31
NCDs
30
Zika
28
Refugee
23
Natural Hazards
23
Conflict
20
Health Financing Toolbox
19
Ebola & Marburg
15
Polio
12
Specific Hazards
4
Cholera
4
Typhoon
4
Social Ethics
1
This Poster is available in English, French, Spanish, Russian, Chinese, Portuguese, Hausa and Arabic
The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organization (WHO) and the UN committed to ending the TB epidemic through adoption of WHO’s End TB Strateg...
Evidence from a systematic review on antenatal zinc supplementation was evaluated as part of the World Health Organization (WHO) antenatal care (ANC) guideline development process in 2016, and the following recommendation on zinc supplementation was made: “Zinc supplementation for pregnant women i...
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
Technical Report
AIDS Medicines and diagnostics service
September 2016
WHO’s total revenue in 2020 was US$ 4299 million and total expenses were US$ 3561 million, resulting in a surplus of US$ 824 million, which includes finance revenue (e.g. interest and investment income) of US$ 86 million, representing increases of 38% and 15% in revenue and expenses respectively. ...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
The objectives of this guideline are the same as those of the 2011 edition, namely to provide evidence-based normative guidance on interventions to improve adolescent morbidity and mortality by reducing the chances of early pregnancy and its resulting poor health outcomes. The specific objectives of...
Schistosomiasis is widely recognized as a disease that is socially determined. An
understanding of the social and behavioural factors linked to disease transmission and
control should play a vital role in designing policies and strategies for schistosomiasis
prevention and control. To this must b...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
Outstanding child and adolescent TB priorities include the need to: find the missing children with active TB and link them to TB care; prevent TB in children who are in contact with infectious TB cases (through implementation of active contact investigation and provision of preventive treatment); an...
